Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

A Milestone in RA Research

David Borenstein, MD, and E. William St.Clair, MD  |  Issue: June 2011  |  June 13, 2011

The Investigators’ Meeting in June 2010 brought together more than 50 investigators from across the U.S. to present data and results from their innovative RA research projects and to find creative ways to work more closely together (see “An Eye on RA Innovations,” in the August 2010 issue, p. 1, for a recap). During this meeting, progress from more than 30 RA studies was presented. Investigators openly shared their research in clinical practice, discussed the link between RA and cardiovascular disease, examined the basis for bone and tissue involvement, and provided evidence for genetic links to the disease.

Sharing early research information and seeking collaborations is not something often seen in the world of highly competitive medical research. The Within Our Reach campaign has shown that investigators can be open to collaboration when they are working together for a common cause with a clear goal: finding a cure for RA.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The Research

The topic areas covered by Within Our Reach span the basic, translational, and clinical realms of research. The applications for this program are evaluated by a study section comprising volunteers with the requisite scientific expertise to prioritize the proposals. Their efforts have created an impressive slate of worthy projects.

For example, Antony Rosen, MD, professor and director of rheumatology at Johns Hopkins University School of Medicine in Baltimore, was among the first group of scientists supported during Within Our Reach, receiving funding for a project to investigate anti-PADI4 immune responses in RA as a marker of disease propagation. Ultimately, this work, which was published in Arthritis & Rheumatism, showed that anti-PADI4 antibodies are specific markers of RA and independently associated with more severe disease.1

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

From the second round of funding, Robert Plenge, MD, director of genetics and genomics in the division of rheumatology, immunology, and allergy at Brigham and Women’s Hospital in Boston, received a Within Our Reach grant to search for genetic predictors of clinical responses to anti–tumor necrosis factor (TNF) therapy. This research was also published in Arthritis & Rheumatism and described a risk allele associated with a clinical response to anti-TNF drugs, a class of biologic modifier that has become a mainstay of treatment for RA.2 In addition, Dr. Plenge was able to leverage funding from his Within Our Reach project to obtain additional funding to form an international collaboration to study the genetic basis of response to anti-TNF therapy.

In the third cycle, Kevin Deane, MD, assistant professor of medicine in the division of rheumatology at the University of Colorado in Denver, received a grant to study the lung as an initial site of immune dysregulation in RA. Other grants related to this topic were awarded in the fourth cycle to Dana P. Ascherman, MD, associate professor of medicine at the University of Miami Miller School of Medicine, and Sonye Danoff, MD, PhD, assistant professor of medicine at Johns Hopkins University School of Medicine, who are looking at biomarkers of RA associated with lung disease. The support of these studies not only reflects their high marks for the quality of the science and innovation, but also the recent interest in the lung as a key player in the pathogenesis of RA.

Page: 1 2 3 | Single Page
Share: 

Filed under:Education & TrainingPresident's PerspectiveResearch Rheum Tagged with:AC&RACR Research and Education FoundationResearchRheumatoid arthritis

Related Articles

    A Look Back & A Look Ahead: ACR Research and Education Foundation Turns 25

    August 1, 2010

    The ACR Research and Education Foundation turns 25

    Rheumatology’s Architect

    March 1, 2008

    Help the REF lay foundations for our future

    Productive Partnership

    August 1, 2009

    The ACR and the REF work closely to support the future of rheumatology

    REF’s Campaign to Support RA Research Nears its Initial Funding Target

    September 1, 2010

    The REF’s campaign to support RA research nears its initial funding target

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences